Apicule is a pioneering platform revolutionizing the pharmaceutical supply chain by streamlining the sourcing and trading of Active Pharmaceutical Ingredients (APIs) also known as drug substances. As a trusted intermediary, we connect pharmaceutical manufacturers, research institutions, and healthcare providers with reputable API suppliers worldwide. Our comprehensive database and advanced search capabilities enable our clients to efficiently navigate the complex landscape of API procurement, ensuring access to high-quality ingredients that meet stringent regulatory standards. At Apicule, we understand that the quality of APIs directly impacts the safety and efficacy of final drug products. Therefore, we meticulously vet our network of suppliers, considering factors such as quality assurance, regulatory compliance, and supply chain resilience. By leveraging our expertise and cutting-edge technology, we empower our clients and drug product manufacturers to make informed decisions, mitigate risks, and ultimately contribute to the development of safe and effective medications for patients globally.
Schering AG was a major German multinational pharmaceutical company, renowned for its research-driven approach and significant contributions to pharmaceuticals, chemicals, and life sciences. Headquartered in Berlin-Wedding, Germany, Schering operated independently from its foundi g in 1851 until its acquisition by Bayer in 2006. - Show More
Hexal develops, manufactures and markets modern generics and innovative pharmaceuticals complex. As a leading provider of patent medicines in Germany Hexal is one of the largest pharmaceutical companies. Hexal makes an important contribution to future patients get medicines they eed. We offer all major therapeutic areas, quality medicines at low cost. Quality and innovation are our top priority. We develop our products base...Hexal develops, manufactures and markets modern generics and innovative pharmaceuticals complex. As a leading provider of patent medicines in Germany Hexal is one of the largest pharmaceutical companies. Hexal makes an important contribution to future patients get medicines they need. We offer all major therapeutic areas, quality medicines at low cost. Quality and innovation are our top priority. We develop our products based on proven drugs targeting further to make their application for the doctor and patients better and easier, for example by offering new dosage strengths and optimized dosage forms. - Show More
IPC Process-Center GmbH & Co. KG is your partner for contract manufacturing of innovative granules and pellets. Experienced staff members create your product on schedule, reliably and in consistent quality. We produce for our customers in our GMP facilities pharmaceutical excipie ts and APIs with tailor made characteristics. As a member of the Glatt group we base our expertise on fluidbed technology but also high shear granul...IPC Process-Center GmbH & Co. KG is your partner for contract manufacturing of innovative granules and pellets. Experienced staff members create your product on schedule, reliably and in consistent quality. We produce for our customers in our GMP facilities pharmaceutical excipients and APIs with tailor made characteristics. As a member of the Glatt group we base our expertise on fluidbed technology but also high shear granulation and direct pelletisation processes are available. Our services cover lab and pilot scale trials as well as validation of the production process. - Show More
Otto Brandes Gmbh was founded in 1923 and is an independent distributor of high quality Pharmaceutical Active Ingredients and excipients for the pharmaceutical industry. We regard ourselves as a service provider and focus on the customer`s interests. Our aim is to work together w th you as a reliable and dependable partner, to achieve your requirements and objectives, enabling you to take a successful market position. Since 20...Otto Brandes Gmbh was founded in 1923 and is an independent distributor of high quality Pharmaceutical Active Ingredients and excipients for the pharmaceutical industry. We regard ourselves as a service provider and focus on the customer`s interests. Our aim is to work together with you as a reliable and dependable partner, to achieve your requirements and objectives, enabling you to take a successful market position. Since 2015 we are a part of an internationally expanding group. - Show More
5N Plus Lübeck GmbH is a German-based manufacturer specializing in high-quality bismuth chemicals, particularly for pharmaceutical applications. The company was founded in 1948 (originally as MCP-HEK GmbH) and is now part of the global 5N Plus group, which is headquartered in Mo treal, Canada. - Show More
Gemini PharmChem Mannheim GmbH is a pharmaceutical company that focuses on modern manufacturing of Active Pharmaceutical Ingredients (APIs). The headquarters – Synbias Pharma AG – are located in Schaffhausen, Switzerland, with our manufacturing and R&D site in Mannheim, Germa y. Gemini PharmChem Mannheim GmbH primary specialization is developing and manufacturing highly potent APIs, mainly used for cancer therapy, inclu...Gemini PharmChem Mannheim GmbH is a pharmaceutical company that focuses on modern manufacturing of Active Pharmaceutical Ingredients (APIs). The headquarters – Synbias Pharma AG – are located in Schaffhausen, Switzerland, with our manufacturing and R&D site in Mannheim, Germany. Gemini PharmChem Mannheim GmbH primary specialization is developing and manufacturing highly potent APIs, mainly used for cancer therapy, including Anthracyclines, Nucleosides and Plant alkaloids. We can produce APIs according to the specific requirements of our customers. We optimize the production processes based on many years of experience and practice. - Show More
IMB is a modern, international research institute in Mainz, Germany. We are a non-profit organisation opened in 2011 with funding from the Boehringer Ingelheim Foundation and the State of Rhineland-Palatinate. Our mission is to answer key questions in how organisms grow, age, and develop disease through basic research in epigenetics, genome stability and related fields. IMB now has over 200 researchers. We attract top studen...IMB is a modern, international research institute in Mainz, Germany. We are a non-profit organisation opened in 2011 with funding from the Boehringer Ingelheim Foundation and the State of Rhineland-Palatinate. Our mission is to answer key questions in how organisms grow, age, and develop disease through basic research in epigenetics, genome stability and related fields. IMB now has over 200 researchers. We attract top students and young scientists from all over the world, with more than half of our PhD students and postdocs coming from abroad. Labs are run with an informal atmosphere and our working language is English. - Show More
